Tonix Pharmaceuticals Holding Corp. focuses on discovering, acquiring, developing,and licensing therapeutics and diagnostics. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company was founded in 2007 and is headquartered in Chatham, New Jersey.
